Skip to content

Clinical Audit of chloroquine effect on malaria in children treated in a medical college hospital of Mangalore , Karnataka.

Retrospective study on the therapeutic efficacy of chloroquine in children with plasmodium vivax malaria,from a tertiary care hospital in Mangalore, Karnataka. - Nil

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/06/007005
Enrollment
300
Registered
2016-06-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Malaria

Interventions

Intervention1: Malaria vivax Infection in children from one month to twelve years treated.: Chloroquine 10mg/kg Day 1 Chloroquine 10mg/kg Day 2 Chloroquine 5mg/kg Day 3 Intervention2: A. Chloroquine

Sponsors

Father Muller Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children between one month and twelve years ,with mono infection of vivax malaria ,treated with choloroquine ,as per Ministry of Health and Family Welfare protocol, Govt of India.

Exclusion criteria

Exclusion criteria: 1.Febrile conditions other than malaria 2.Malaria caused by Plasmodium falciparum or mixed infection. 3.Drugs other than chloroquine when used in treatment of vivax malaria. 4.Patient who could not complete course of treatment as inpatients. 5.Children with severe malnutrition

Design outcomes

Primary

MeasureTime frame
Elimination of clinical symptoms of Malaria. Laboratory evidence of parasite clearance after day 3.Timepoint: Fever less than 99 F over 48hours.

Secondary

MeasureTime frame
Drug induced adverse effects, relapse, recurrence, recrudescence and resistance of malaria.Timepoint: 2 weeks and 4 weeks after discharge

Countries

India

Contacts

Public ContactProf K Varadaraj Shenoy

Father Muller Medical College

vskudpi@rediff.com09448143509

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026